Foundation Accepting Letters of Intent for 2025 Grants

The Doctors Company Foundation is currently accepting Letters of Intent for its 2025 grant cycle. Since the Foundation’s inception in 2008, it has provided more than $8.57 million in grants to support patient safety research, education, and training to improve clinical outcomes.

The Foundation seeks applicants who can demonstrate innovative approaches, produce measurable patient/clinician outcomes, and disseminate findings that result in widespread use to improve patient safety across the healthcare community.

Review grant eligibility and criteria, and learn more about the application process.

Letters of Intent will be accepted through the end of business on Wednesday, March 19, 2025.

View the past five years of grants awarded, and read case studies from recent grantees who have concluded their research.

The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.